Balloon pulmonary angioplasty in the current era of CTEPH treatment: How did we get here?
Abstract Chronic thromboembolic pulmonary hypertension (CTEPH) is caused by persistent organized thromboembolic obstruction of the pulmonary arteries from incompletely resolved pulmonary embolism. The treatment of choice is pulmonary thromboendarterectomy (PTE) surgery and all patients should be eva...
Main Authors: | Jenny Z. Yang, David S. Poch, Lawrence Ang, Ehtisham Mahmud, Nick H. Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-10-01
|
Series: | Pulmonary Circulation |
Subjects: | |
Online Access: | https://doi.org/10.1002/pul2.12312 |
Similar Items
-
Patient selection for balloon pulmonary angioplasty: Six‐year results from a high volume PTE surgical center
by: David S. Poch, et al.
Published: (2022-10-01) -
Balloon pulmonary angioplasty can be an effective and safe therapeutic option in non-surgical elderly patients
by: Maite Velázquez Martín, et al.
Published: (2022-10-01) -
Balloon pulmonary angioplasty outcomes in patients previously treated by pulmonary endarterectomy surgery are inferior to those of inoperable patients
by: Louise C. Kirkby, et al.
Published: (2023-07-01) -
Acute lung injury after balloon pulmonary angioplasty results in a similar haemodynamic response and possible clinical advantage at follow‐up
by: Matthew S. Rodgers, et al.
Published: (2022-10-01) -
Different response of the oxygen pathway in patients with chronic thromboembolic pulmonary hypertension treated with pulmonary endarterectomy versus balloon pulmonary angioplasty
by: Zhihui Fu, et al.
Published: (2022-09-01)